Defiance Daily Target 2X Long ORCL ETF (NASDAQ:ORCX – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 911,544 shares, an increase of 80.8% from the June 15th total of 504,195 shares. Currently, 8.7% of the company’s stock are short sold. Based on an average daily volume of 1,835,084 shares, the days-to-cover ratio is presently 0.5 days.
Defiance Daily Target 2X Long ORCL ETF Price Performance
NASDAQ:ORCX opened at $16.43 on Friday. Defiance Daily Target 2X Long ORCL ETF has a fifty-two week low of $16.27 and a fifty-two week high of $181.59. The stock has a market capitalization of $172.35 million, a PE ratio of 35.86 and a beta of 5.94. The business’s 50-day simple moving average is $37.09 and its 200-day simple moving average is $35.97.
Institutional Trading of Defiance Daily Target 2X Long ORCL ETF
A hedge fund recently bought a new stake in Defiance Daily Target 2X Long ORCL ETF stock. Flow Traders U.S. LLC purchased a new stake in Defiance Daily Target 2X Long ORCL ETF (NASDAQ:ORCX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 15,453 shares of the company’s stock, valued at approximately $615,000. Flow Traders U.S. LLC owned approximately 0.23% of Defiance Daily Target 2X Long ORCL ETF as of its most recent filing with the Securities and Exchange Commission (SEC).
Defiance Daily Target 2X Long ORCL ETF Company Profile
The Defiance Daily Target 2X Long ORCL ETF (ORCX) is an exchange-traded fund that mostly invests in information technology equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of Oracle Corporation (ORCL), less fees and expenses, through derivatives like swap agreements. ORCX was launched on Feb 6, 2025 and is issued by Defiance.
Featured Stories
- Five stocks we like better than Defiance Daily Target 2X Long ORCL ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Defiance Daily Target 2X Long ORCL ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long ORCL ETF and related companies with MarketBeat.com's FREE daily email newsletter.
